SolitaryMan

by | Jan 1, 2010

A Pharmaceutical Product-Placement Film

review by Jim West

Solitary Man

(2010)

You are reading a unique film review.

There is a way to enjoy any Hollywood film by studying its game, “product placement.” These films always sell something subliminally, usually a medical or social behavior product. It’s not just Corn Flakes on the kitchen table. Product placement is an essential, subtle skill, routinely taught in film production schools. I look for those techniques, plotistic, poetic, photographic, and audio-musical. Reviews and interviews do not mention product placement unless it is overly obvious. The obvious placements maintain the subliminality of the more subtle placements.

Writer-director Brian Koppelman admits what Solitary Man is about: his writing. “It’s a story about the power of charm … how a truly charming man can get away with so much … until it starts becoming really corrosive from the inside out.”

This is a dark comedy, filmed in the vicinity of New York City.  It is a pharmaceutical product placement film, starring Michael Douglas as Ben, a good-man-gone-bad; Susan Sarandon as Nancy, his sensible ex-wife; and Danny DeVito as Jimmy, his longtime friend. Ben, aged 60, is the protagonist, a charismatic family man and famously honest car dealer with business and social influence.

Advertisement

The film launches with a flashback, six years earlier, with Ben receiving a negative electrocardiogram (EKG) report. He avoids the recommended visit to heart specialists, then begins an immediate downslide, cheating on his wife with very young girls, subverting his business reputation, and divorcing. It continues with Ben romping through ruin and escapism, yet he never shows remorse or fatigue. He has sex with his daughter’s girlfriend, and sex with his girlfriend’s daughter. He hits on his friend’s girlfriend. Up all night having sex, he misses his grandson’s birthday, then arrives with cake and gifts to entertain the boy with video games until late, as a “hero.”

Throughout this cinematic character study, Ben’s task, every morning before getting out of bed, is to swallow prescription drugs. At least four medical products are promptly sold (placed), and pounded in throughout the film.

Product 1: The EKG, with its long-ranging implications of doom and orthodox salvation, is supported by the fear-motivated drug ritual.

Product 2: Drug efficacy is verified as the magic that carries Ben through the numerous affairs and allows him to be the star of his grandson’s birthday.

Product 3: Drugs are sold as a treat. Ben’s irresponsibility promotes a social ploy, allowed for buying into the orthodox paradigm. Here’s the deal. If you receive a negative EKG, you too can go on a prescription-drug binge. As a certified victim, you deserve it.

Product 4: Various orthodox paradigms are verified by Ben’s status. He is a well-networked, financial genius with access to the best orthodox medical expertise, so his escapism implies realistic fears.

The Denton-Record Chronicle (June 6, 2010) described the surface plot, “Solitary Man stars Michael Douglas as a man whose bad decisions have resulted in him losing almost everything. …” The more perceptive San Francisco Examiner (June 4, 2010) almost stumbles into something meaningful: “The use of the EKG to explain Ben’s nosedive is unnecessary and plays like a sympathy device.” 

Yet the EKG is essential. Who otherwise would bankroll the film and lobby its high ratings? The EKG establishes the underlying suspense, which requires watching the entire movie to discover whether Ben will continue irresponsibly, learn his moral lesson, or have another heart attack.

The plot details the last year of Ben’s downslide with him eventually tossing burgers at Jimmy’s deli. A few more irresponsible snafus, and Ben is on parking lot asphalt with several ribs broken by a professional strong-arm who is shouting at him to stay away from the local college campus. The strong-arm punches Ben many times, deep into the upper solar-plexus, framed too obviously.

The finale: In the hospital, Ben awakes from a drug-induced sleep or coma with the nurse explaining, “They had to give you pain killers to prevent you from moving and damaging your organs.” That line stood out oddly, because pain itself prevents us from moving and damaging organs. That line, however, rationalizes the concept of drug-induced coma. Let’s add a Product 5.

In the closing scene, Ben and his ex-wife (Sarandon) are sitting on a park bench. She recounts his sins, his evasions of responsibilities, and focuses the final line upon Ben’s avoidance of heart specialists, with, “You can’t cheat that.” She then stands up and walks stage right to await in her car, his decision. Unexpectedly a young girl walks across the screen, stage left. The film ends with Ben staring straight ahead into the camera, torn between young girls and his fate with the heart specialists. 

Caught another one, Product 6: Sarandon models the role of commonsense sheepherder for pharmaceutical paradigms. The image of her (wise) and Ben (beaten), sitting on a park bench, captures this well. Ben has become estranged, immoral, and punished as a Solitary Man, following his escapist response to the EKG. Sarandon is waiting for him as backup. What’s in those pills? The film equates Ben’s moral faults with his avoidance of medical orthodoxy. I would prefer the film not end with Sarandon’s, “You can’t cheat that.”

Here’s a better ending. “Ben, you should have listened to your symptoms. The problem was our unventilated gas stove, which can cause various health problems. That’s fixed.”

And they lived happily ever after.

Author

Already Subscribed?

Search

Formatting updates are ongoing for older articles.

Author

Featured Articles

Where are your Clinical Trials?

It has proven to be difficult, if not impossible, to proceed to full-scale randomized controlled trials (RCTs) for most of the natural methods that cannot be patented or otherwise monopolized. 

A Renewed Focus on Self-Help for Healing

As the producer of The Moss Report, the year leading up to the Covid-19 pandemic was filled with anticipation and excitement. We had invested years of hard work and significant resources into two major projects: our feature film, Immunotherapy: The Battle Within, and...

Issue Archives

Event Calendar

  • Integrative Cancer Symposium 2026 – Believe BIG

    Sheraton, Towson MD Towson, MD, United States

    Optimize Your Health. Transform Your Future. Join us for this dynamic one-day experience designed for anyone seeking to take a proactive, whole-body approach to health. Integrative oncology is a dynamic and rapidly evolving field, unveiling groundbreaking discoveries and new possibilities every day. This year’s one-day conference will take place at the Sheraton in Towson, Maryland from 9am – 5pm and offers both in-person and virtual attendance options. This event brings together leading experts in integrative oncology, functional medicine, and wellness. Discover cutting-edge approaches to prevention, treatment, recovery, and whole-person wellness at the Integrative Cancer Symposium Believe Big 2026. Learn from leading clinicians, researchers, and innovators in integrative oncology as they explore emerging therapies, metabolic and lifestyle approaches, mistletoe therapy, nutrition, environmental health, mindset, and more. Whether you are navigating cancer personally, supporting a loved one, or simply looking to optimize your health and reduce future risk, this powerful one-day experience offers practical tools, fresh insights, and meaningful connection.

  • PLMI 14th Annual Thought Leaders Consortium

    Loews Coronado Bay Resort 4000 Coronado Bay Rd, Coronado, CA, United States

    The 14th Annual Thought Leaders Consortium marks the culminating chapter of PLMI’s three-year exploration into the biology of immuno-metabolism, epigenetic regulation, and human longevity. Building on the 2024 and 2025 Consortia—which reframed chronic disease through immune-metabolic dysfunction and diet- and environment-driven epigenetic remodeling—this year’s gathering places mitochondria at the center of health, disease, and aging. Once viewed simply as the cell’s energy producers, mitochondria are now recognized as dynamic, epigenetically responsive organelles that integrate nutrition, environmental exposures, immune activation, stress signaling, physical activity, and circadian inputs into a unified metabolic-immune system. Disruption of mitochondrial function is increasingly implicated in fatigue syndromes, chronic pain, immune dysregulation, neurodegeneration, infertility, metabolic disease, accelerated aging, and diminished stress resilience. This advanced, science-driven Consortium convenes world-leading experts to explore mitochondrial biology as the cornerstone of immuno-metabolic resilience. Attendees will gain cutting-edge insights into mitochondrial signaling, mito-nuclear communication, and metabolic flexibility—alongside clinically actionable frameworks for restoring cellular vitality, reversing biological aging trajectories, and extending healthspan. Through deep scientific exploration and translational clinical strategy, the 2026 Thought Leaders Consortium will equip practitioners and researchers with the knowledge needed to redefine assessment, intervention, and long-term outcomes in personalized and lifestyle medicine.

    $650
  • Practical Clinical Skills in Neurotransmitter Optimization: Clinical Herbalism for Mood, Cognition & Aging

    Virtual Event

    Join us for the second part of this two-part virtual symposium! Mental health and neurocognitive disorders remain among the most prevalent and inadequately addressed challenges in modern clinical practice.  This intensive, expert-led symposium provides a comprehensive, clinically grounded framework for integrating herbal and nutraceutical strategies into mental health care. Attendees gain a working understanding of how targeted herbal interventions modulate key neurotransmitter systems, including serotonin, dopamine, GABA, and cortisol, and how to apply these therapies strategically, whether as adjuncts to pharmaceuticals or as standalone options. Clinical applications span a wide spectrum, from anxiety and depression to Parkinson’s-related motor symptoms and age-associated cognitive decline, with a strong emphasis on practical implementation and patient-specific protocol design.

Related Posts

The GMO-to-Cancer Pathway

By Michelle Perro, MD – Early-onset colorectal cancer, generally defined as colorectal cancer diagnosed before age 50, has been rising for decades. The phenomenon is particularly disturbing because many cases occur in people without an obvious hereditary cancer syndrome.

Read More

0 Comments

Submit a Comment

Pin It on Pinterest

Share This